The Lancet Gastroenterology & Hepatology in conversation with

Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

March 12, 2024 The Lancet Group
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
The Lancet Gastroenterology & Hepatology in conversation with
More Info
The Lancet Gastroenterology & Hepatology in conversation with
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
Mar 12, 2024
The Lancet Group

Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake.

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Show Notes

Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake.

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv